Therapeutic approaches for shankopathies

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Current autism spectrum disorder (ASD) treatments primarily rely on behavioral and educational strategies.
• The molecular heterogeneity of ASD complicates the development of targeted therapies.
• SHANK gene deficiencies are strongly implicated as causative factors in ASD.

Purpose of the Study:

• To review literature on developing molecular therapies for ASD based on SHANK gene function.
• To discuss emerging themes from studying Shank mutant mouse models.
• To explore potential therapeutic strategies targeting molecular defects and synaptic function in ASD.

Main Methods:

• Literature review of genetic evidence linking SHANK genes to ASD.
• Analysis of studies utilizing Shank mutant mouse models.
• Examination of molecular and synaptic function data from these models.

Main Results:

• Strong genetic evidence supports SHANK genes as key players in ASD.
• Shank mutant mouse models offer valuable platforms for investigating ASD mechanisms.
• Research highlights potential for molecular interventions targeting SHANK-related pathways.

Conclusions:

• SHANK gene deficiencies present a viable target for novel molecular therapies in ASD.
• Studying Shank mutant mice provides critical insights into ASD's molecular and synaptic underpinnings.
• Further research into Shank-related pathways could lead to effective ASD treatments.